Ragweed allergy immunotherapy - Stallergenes Greer plc

Drug Profile

Ragweed allergy immunotherapy - Stallergenes Greer plc

Alternative Names: Ragweed pollen extract - Stallergenes Greer plc; Ragweed SLIT tablets - Stallergenes Greer plc; STAGR SAIL™ SLIT

Latest Information Update: 26 Apr 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Stallergenes SA
  • Developer Stallergenes Greer plc
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Seasonal allergic rhinitis

Most Recent Events

  • 30 Nov 2012 Clinical development is ongoing
  • 26 Oct 2010 Stallergenes completes a phase I trial in Seasonal allergic rhinitis in Hungary
  • 01 Jan 2009 Phase-I clinical trials in Seasonal allergic rhinitis in Hungary (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top